← Leaderboards
Dionna Whitney Williams
Johns Hopkins University
$7,052,122
Attributed
$11,775,423
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,775,423 · 5
By mechanism
U01$7,084,951 · 1
R01$3,573,012 · 1
R00$816,962 · 1
K99$275,498 · 1
R13$25,000 · 1
Top collaborators
- Michael Jay Corley3 shared
- Lishomwa C Ndhlovu3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Ned C Sacktor$10,719,879
- John Patrick Carey$6,481,437
- Amanda M Lauer$7,656,167
- Suzanne Gartner$7,702,037
- Katherine E Conant$7,277,433
Others in their field
Other Emerging Leaders on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Evan Z Macosko · Broad Institute, Inc.$36,871,464
- Greg Yothers · University Of Chicago$35,003,821
- Anthony Philippakis · University Of California Santa Cruz$30,961,549
Research focus
BrainNeuroinflammationAntiretroviral TherapyHiv InfectionsPathway InteractionsMicrogliaComorbidityPharmaceutical PreparationsMacrophageMediatingPeripheralEffectivenessCannabinoidsVirus ReplicationMacacaPrevalenceImpaired CognitionInflammationAnti-Inflammatory AgentsCannabidiolAffectViralCannabisCells
Grant awards (18)
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure$2,276,913
U01 · FY2025 · DA
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure$2,276,913
U01 · FY2024 · DA
Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model$640,462
R01 · FY2024 · DA · contact PI
2024 Barriers of the CNS Gordon Research Conference and Seminar$25,000
R13 · FY2024 · NS · contact PI
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure$2,531,125
U01 · FY2023 · DA
Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model$623,800
R01 · FY2023 · DA · contact PI
Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model$112,726
R01 · FY2023 · DA · contact PI
Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model$626,485
R01 · FY2022 · DA · contact PI
Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model$109,586
R01 · FY2022 · DA · contact PI
Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model$630,785
R01 · FY2021 · DA · contact PI
COCAINE USE AND HIV ANTIRETROVIRAL THERAPY EFFICACY IN THE CNS$242,602
R00 · FY2021 · DA · contact PI
Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model$162,676
R01 · FY2021 · DA · contact PI
Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model$666,492
R01 · FY2020 · DA · contact PI
COCAINE USE AND HIV ANTIRETROVIRAL THERAPY EFFICACY IN THE CNS$244,152
R00 · FY2020 · DA · contact PI
COCAINE USE AND HIV ANTIRETROVIRAL THERAPY EFFICACY IN THE CNS$81,875
R00 · FY2020 · DA · contact PI
COCAINE USE AND HIV ANTIRETROVIRAL THERAPY EFFICACY IN THE CNS$248,333
R00 · FY2019 · DA · contact PI
Cocaine Use and HIV Antiretroviral Therapy Efficacy in the CNS$137,749
K99 · FY2018 · DA · contact PI
Cocaine Use and HIV Antiretroviral Therapy Efficacy in the CNS$137,749
K99 · FY2017 · DA · contact PI